Novagali Articles

Santen Pharma progresses acquisition of Novagali, gaining 50.55% stake

13 October 2011

French eye-products firm Novagali said to be in takeover talks with Sanofi-Aventis and considering IPO, says Les Echos; Good lixisenatide data

15 April 2010

Showing 1-2 of 2 articles

Go to beginningPrevious
  • 1
NextGo to end